Article Text

Download PDFPDF
Surgical management and genetic analysis of a Chinese family with the S171P mutation in the UBIAD1 gene, the gene for Schnyder corneal dystrophy
  1. J S Mehta1,2,
  2. E N Vithana1,3,
  3. D Venkataraman1,
  4. A Venkatraman1,
  5. V H K Yong1,
  6. T Aung1,2,3,
  7. D T H Tan1,2,3
  1. 1
    Singapore Eye Research Institute, Singapore
  2. 2
    Singapore National Eye Centre, Singapore
  3. 3
    Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  1. Dr J S Mehta, Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore 168751; jodmehta{at}


Background: To describe the underlying molecular genetic basis, surgical management and phenotypic variation of Schnyder corneal dystrophy (SCD) identified in a four-generation Chinese family.

Methods: This is an interventional case series of 13 members from a non-consanguineous Chinese family. All patients underwent complete ophthalmological examination and slit-lamp photography. Subsequent corneal transplantations were performed (n = 3). Blood samples were taken for DNA extraction and subsequent genetic analysis.

Results: Genotyping indicated linkage to the locus at chromosome 1p36. Screening of the UBIAD1 gene identified a highly conserved mutation, Ser171Pro. Phenotypic variation in this large pedigree is similar to that seen in Caucasian patients. Surgical management of patients with anterior lamellar keratoplasty and deep anterior lamellar keratoplasty showed good visual outcomes.

Conclusions: The S171P mutation is described for the first time in a Chinese family. This is the largest non-Caucasian pedigree described with SCD. Visual rehabilitation may be performed successfully with lamellar surgical procedures as opposed to full-thickness corneal grafts.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

  • Ethics approval: Ethics approval was provided by Singapore National Eye Centre IRB.

  • Patient consent: Obtained.